Mirae Asset Global Investments Co., Ltd. Prothena Corp Public LTD CO Transaction History

Mirae Asset Global Investments Co., Ltd.

$22.5 Billion
Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,945 shares of PRTA stock, worth $28,941. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,945

Previous 1,605 21.18%

Holding current value

$28,941

Previous $33,000 3.03%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$16.73 - $24.79 $5,688 - $8,428	340 Added 21.18%	1,945 $32,000
Q2 2024 Jul 30, 2024	SELL	$19.54 - $26.15 $514,038 - $687,928	-26,307 Reduced 94.25%	1,605 $33,000
Q1 2024 May 01, 2024	BUY	$24.75 - $40.66 $3,984 - $6,546	161 Added 0.58%	27,912 $691,000
Q4 2023 Jan 24, 2024	BUY	$32.31 - $52.32 $67,818 - $109,819	2,099 Added 8.18%	27,751 $1.01 Million
Q3 2023 Oct 26, 2023	BUY	$47.3 - $70.6 $152,400 - $227,473	3,222 Added 14.36%	25,652 $1.24 Million
Q2 2023 Aug 10, 2023	SELL	$48.26 - $78.59 $66,984 - $109,082	-1,388 Reduced 5.83%	22,430 $1.53 Million
Q1 2023 May 04, 2023	BUY	$46.97 - $58.27 $334,144 - $414,532	7,114 Added 42.59%	23,818 $1.15 Million
Q4 2022 Feb 09, 2023	BUY	$52.05 - $65.0 $2,758 - $3,445	53 Added 0.32%	16,704 $1.01 Million
Q3 2022 Nov 10, 2022	BUY	$25.16 - $60.63 $144,946 - $349,289	5,761 Added 52.9%	16,651 $1.01 Million
Q2 2022 Jul 26, 2022	BUY	$22.73 - $39.98 $231,209 - $406,676	10,172 Added 1416.71%	10,890 $296,000
Q2 2021 Aug 11, 2021	BUY	$21.63 - $57.65 $15,530 - $41,392	718 New	718 $37,000
Q4 2017 Feb 12, 2018	SELL	$35.44 - $63.76 $117,341 - $211,109	-3,311 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$53.83 - $67.75 $178,231 - $224,320	3,311	3,311 $214,000

Others Institutions Holding PRTA

# of Institutions

184

Shares Held

42.7M

Call Options Held

162K

Put Options Held

102K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $698M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Prothena Corp Public LTD CO Transaction History